Developing better ways to detect multiple types of cancer early.
Official title: Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN)
Funded at Fred Hutchinson Cancer Center · NIH-11032889 · Data updated 2026-11-12
This study is testing new tests that can help find different types of cancer early, especially those that are hard to detect, and it's for people who want to be part of research that could improve cancer screening for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | February 12, 2024 |
| Project end | December 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $1,459,017 |
| NIH project number | 5UG1CA287013-02 |
| Project ID | NIH-11032889 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at average risk for various types of cancer who are interested in participating in screening trials.
✕Less likely to help
Patients with existing cancer diagnoses or those at high risk for specific cancers may not benefit directly from this research.
What this research studies
This research focuses on creating and evaluating multi-cancer detection assays that can screen for various cancers, especially those with limited early detection options. The Cancer Screening Research Network (CSRN) will conduct clinical trials to assess the effectiveness of these assays. The project involves careful planning to address challenges such as trial design, participant adherence, and data management. By utilizing a robust statistical and data management approach, the research aims to provide reliable information that can influence national cancer screening policies.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection of multiple cancers, potentially saving lives through timely intervention.
How similar studies have gone: Previous research has shown promise in multi-cancer detection approaches, indicating potential for success in this novel application.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Kooperberg, Charles L — Fred Hutchinson Cancer Center
- Study coordinator: Kooperberg, Charles L
Related research
Other NIH-funded projects on the same topics.
-
How brain glia prune neuron fragments in a worm model
Researchers study how brain support cells called glia remove pieces of living neurons in a tiny worm to learn about brain aging and diseases like Alzheimer's.
-
Understanding and Targeting Lineage Plasticity in Prostate Cancer with Genomic-Based Neoadjuvant Therapy
A broad research program at Fred Hutchinson Cancer Center is exploring how aggressive prostate cancers change their cell states in response to therapy and how to block these changes.
-
Personalized cancer drug testing on patient tumor cells
Aiming to test many FDA-approved cancer drugs on a patient’s own tumor cells to identify effective options when standard therapies fail.
-
MOSAAIC: Using health records to track heart disease in Asian American Communities
A big, dedicated effort is testing whether electronic health records can more quickly and accurately track heart and blood vessel problems in Asian American populations.
-
Targeting gut microbes to prevent progression to multiple myeloma
Researchers are testing how specific gut bacteria might trigger immune changes linked to early blood cancer stages and whether targeting these microbes could help prevent progression to multiple myeloma.
-
eDyNAmiC: Understanding extrachromosomal DNA in cancer and how it drives aggressiveness
A cancer research project at Fred Hutchinson Cancer Center is studying abnormal circular DNA pieces (ecDNA) that help cancers grow and resist treatment, with the aim of finding ways to help patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.